IntraBio Announces U.S. FDA Approval of AQNEURSA® (levacetylleucine) for Ataxia — Telangiectasia
For best results when printing this announcement, please click on link below: IntraBio Announces U.S. FDA Approval of AQNEURSA® (levacetylleucine) for Ataxia-Telangiectasia First and only approved treatment indicated for Ataxia-Telangiectasia (A-T) in the United States or anywhere in the world Second FDA-approved indic